Omega Therapeutics, Inc.

NASDAQ:OMGA

1.43 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 2.1342.360.9890.8310.7590.5160.7350.5950.4760.2680.1440000000
Kosten van de omzet 0.6131.8161.7811.8641.8191.3071.3151.3211.3181.2260.3840.40.30.30221.063000
Brutowinst 1.5210.544-0.792-1.033-1.06-0.791-0.58-0.726-0.842-0.958-0.24-0.4-0.3-0.302-21.063000
Brutowinstmarge 0.7130.231-0.801-1.243-1.397-1.533-0.789-1.22-1.769-3.575-1.6670000000
Onderzoek- en ontwikkelingskosten 12.9415.41515.53116.47525.01219.96825.66720.6719.38714.19114.64312.28911.1849.7487.1425.5054.8953.521
Algemene en administratieve kosten 5.7747.3966.1567.8696.2065.9545.3555.1986.2025.4065.6924.4593.6372.7451.8142.0471.011.365
Verkoop- en marketingkosten 0.687-1.816-1.78000000000000000
Verkoop-, algemene en administratieve kosten 5.1615.584.3767.8696.2065.9545.3555.1986.2025.4065.6924.4593.6372.7451.8142.0471.011.365
Overige kosten -0.024-0.009-0.002-0.0290.1960.4120.680.7120.7410.63-0.0210.002-0.004-0.0040.286-0.0010.2250.004
Bedrijfskosten 18.10120.99519.90724.34431.59926.33431.70226.5826.3320.22720.80817.22115.20512.9429.2428.0456.135.228
Bedrijfsresultaat -16.58-20.451-20.699-22.903-30.84-25.818-30.967-25.985-25.854-19.959-20.664-17.221-15.205-12.942-9.242-8.045-6.13-5.228
Bedrijfsresultaat ratio -7.769-8.666-20.929-27.561-40.632-50.035-42.132-43.672-54.315-74.474-143.50000000
Totaal overige inkomsten en kosten netto 0.2750.3220.4850.6550.1960.5390.1410.186-0.058-0.205-0.021-0.968-0.015-0.334-0.03-0.1960.0010.004
Inkomen voor belasting -16.305-20.129-20.214-22.248-29.687-25.279-30.826-25.799-25.912-20.164-20.854-18.528-15.41-13.488-9.465-8.241-6.323-5.418
Inkomen voor belasting ratio -7.641-8.529-20.439-26.773-39.113-48.99-41.94-43.36-54.437-75.239-144.8190000000
Belastingkosten -01.7734.042-1.864-0.957-1.221-0.141-0.1860.0580.2050.191.3070.0110.5460.2230.196-0.0010.19
Nettowinst -16.305-20.129-20.214-22.248-29.687-24.058-30.685-25.613-25.97-20.369-20.854-18.528-15.41-13.488-9.465-8.241-6.323-5.418
Nettowinstmarge -7.641-8.529-20.439-26.773-39.113-46.624-41.748-43.047-54.559-76.004-144.8190000000
WPA (Winst Per Aandeel) -0.3-0.36-0.37-0.4-0.54-0.48-0.64-0.54-0.54-0.43-0.44-0.57-0.33-0.43-0.3-0.26-0.2-0.17
Verwaterde WPA -0.3-0.36-0.37-0.4-0.54-0.48-0.64-0.54-0.54-0.43-0.44-0.57-0.33-0.43-0.3-0.26-0.2-0.17
EBITDA -15.967-18.635-18.918-22.903-29.021-25.818-30.967-25.591-25.447-19.633-20.301-16.855-14.872-12.644-8.841-7.772-5.905-5.012
EBITDA ratio -7.482-7.896-19.128-27.561-38.236-50.035-42.132-43.01-53.46-73.257-140.9790000000